Benign Prostatic Hyperplasia Treatment Market with COVID-19 Impact Analysis, By Treatment (Drug Class, Minimally Invasive Surgeries, and Laser Therapy), By End User and By Region Industry Analysis, Market Size, Market Share & Forecast from 2022-2028
REPORT HIGHLIGHT
Benign Prostatic Hyperplasia Treatment Market size was valued at USD 12,080.1 Million in 2021, expanding at a CAGR of 4.8% from 2022 to 2028.
Benign prostatic hyperplasia (BPH) is a condition that worsens with time and causes the prostate to enlarge either naturally or as a result of a disease. The likelihood of benign prostatic hyperplasia considerably rises with age. Thus, it increases the need for proper medical treatment.
Market Dynamics
BPH medicines, surgery, and minimally invasive surgery are among viable medical treatments for BPH cures. Increased knowledge of the existence of medications for benign prostatic hyperplasia and an increase in the prevalence of benign prostatic hyperplasia are expected to provide ample growth opportunities for the market worldwide and the benign prostatic hyperplasia prostate treatment industry.
Further, the growth of the old-age population, which is more susceptible to age-related and chronic diseases, is anticipated to drive the size of the global benign prostatic hyperplasia treatment market. These patients typically require more treatment for benign prostatic hyperplasia. Due to numerous benefits like less post-operative pain, less blood loss, shorter hospital stays, and a quicker recovery, minimally invasive operations are becoming more and more popular. This is probably going to increase the demand for treatments for benign prostatic hyperplasia (BPH) worldwide. COVID-19 has had a positive impact on the market as the rising health concerns and rising coronavirus cases in older adults have resulted in a high need for BPH treatment.
Segmentation Analysis:
The global benign prostatic hyperplasia treatment market is segmented on the basis of treatment, end user, and region.
The market is divided into four categories based on Treatment: minimally invasive surgeries, drug class, laser therapy, and others. Of these, the minimally invasive surgeries segment dominates the market. Several factors such as the high need for therapies in transurethral, and robotic surgeries are boosting segment growth.
The market is divided into three categories based on End Users: hospitals and clinics, ambulatory surgical centers, and others. The hospitals and clinics segment dominates the market and is likely to maintain its dominance during the forecast period. This is partly due to an increasing need for adoption across hospitals and clinics.
Competitive Landscape:
The global Benign Prostatic Hyperplasia Treatment market is highly comprised of small and large players with large players dominating the global market. Companies are concentrating on developing effective therapy solutions for benign prostatic hyperplasia treatment. These substances are made to be environmentally beneficial and biodegradable. Some of the primary techniques used by corporations to strengthen their reach and expand their market share include new product launches, partnerships, distribution network development, R&D spending, and mergers and acquisitions.
For instance, in April 2022, Teleflex announced the launch of the UroLift System in Japan for the treatment of benign prostatic hyperplasia (BPH).
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL BENIGN PROSTATIC HYPERPLASIA TREATMENT MARKET KEY PLAYERS
- Abbott
- Boehringer Ingelheim GmbH
- GlaxoSmithKline plc
- Pfizer, Inc.
- Sanofi
- Merck & Co., Inc.
- Teva Pharmaceutical Industries Ltd.
- Boston Scientific Corporation
- Teleflex Incorporated
- Endo International plc
- Urologix, LLC
- LISA Laser Surgeries
- Olympus Corporation
GLOBAL BENIGN PROSTATIC HYPERPLASIA TREATMENT MARKET, BY TREATMENT
- Drug Class
- Minimally Invasive Surgeries
- Laser Therapy
- Others
GLOBAL BENIGN PROSTATIC HYPERPLASIA TREATMENT MARKET, BY END USER
- Hospitals and Clinics
- Ambulatory Surgical Centers
- Others
GLOBAL BENIGN PROSTATIC HYPERPLASIA TREATMENT MARKET, BY REGION
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Benign Prostatic Hyperplasia Treatment Market Overview
1.1. Study Scope
2. Executive Summary
2.1. Market Snippet
2.1.1. Market Snippet by Treatment
2.1.2. Market Snippet by End User
2.1.3. Market Snippet by Country
2.1.4. Market Snippet by Region
2.2. Competitive Insights
3. Benign Prostatic Hyperplasia Treatment Key Market Trends
3.1. Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Market Opportunities
3.4. Market Future Trends
4. Benign Prostatic Hyperplasia Treatment Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Benign Prostatic Hyperplasia Treatment Market: COVID-19 Impact Analysis
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. Benign Prostatic Hyperplasia Treatment Market Landscape
6.1. Market Share Analysis, 2021
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Benign Prostatic Hyperplasia Treatment Market – By Treatment
7.1. Overview
7.1.1. Segment Share Analysis, By Treatment, 2021 & 2028 (%)
7.1.2. Drug Class
7.1.3. Minimally Invasive Surgeries
7.1.4. Laser Therapy
7.1.5. Others
8. Benign Prostatic Hyperplasia Treatment Market – By End User
8.1. Overview
8.1.1. Segment Share Analysis, By End User, 2021 & 2028 (%)
8.1.2. Hospitals and Clinics
8.1.3. Ambulatory Surgical Centers
8.1.4. Others
9. Benign Prostatic Hyperplasia Treatment Market– By Geography
9.1. Introduction
9.1.1. Segment Share Analysis, By Geography, 2021 & 2028 (%)
9.2. North America
9.2.1. Overview
9.2.2. Key Manufacturers in North America
9.2.3. North America Market Size and Forecast, By Country, 2017 - 2028 (US$ Million)
9.2.4. North America Market Size and Forecast, By Treatment, 2017 - 2028 (US$ Million)
9.2.5. North America Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
9.2.6. U.S.
9.2.6.1. Overview
9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
9.2.6.3. U.S. Market Size and Forecast, By Treatment, 2017 - 2028 (US$ Million)
9.2.6.4. U.S. Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
9.2.7. Canada
9.2.7.1. Overview
9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
9.2.7.3. Canada Market Size and Forecast, By Treatment, 2017 - 2028 (US$ Million)
9.2.7.4. Canada Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
9.3. Europe
9.3.1. Overview
9.3.2. Key Manufacturers in Europe
9.3.3. Europe Market Size and Forecast, By Country, 2017 - 2028 (US$ Million)
9.3.4. Europe Market Size and Forecast, By Treatment, 2017 - 2028 (US$ Million)
9.3.5. Europe Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
9.3.6. Germany
9.3.6.1. Overview
9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
9.3.6.3. Germany Market Size and Forecast, By Treatment, 2017 - 2028 (US$ Million)
9.3.6.4. Germany Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
9.3.7. Italy
9.3.7.1. Overview
9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
9.3.7.3. Italy Market Size and Forecast, By Treatment, 2017 - 2028 (US$ Million)
9.3.7.4. Italy Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
9.3.8. United Kingdom
9.3.8.1. Overview
9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
9.3.8.3. United Kingdom Market Size and Forecast, By Treatment, 2017 - 2028 (US$ Million)
9.3.8.4. United Kingdom Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
9.3.9. France
9.3.9.1. Overview
9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
9.3.9.3. France Market Size and Forecast, By Treatment, 2017 - 2028 (US$ Million)
9.3.9.4. France Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
9.3.10. Russia
9.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
9.3.10.2. Russia Market Size and Forecast, By Treatment, 2017 - 2028 (US$ Million)
9.3.10.3. Russia Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
9.3.11. Netherlands
9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
9.3.11.2. Netherlands Market Size and Forecast, By Treatment, 2017 - 2028 (US$ Million)
9.3.11.3. Netherlands Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
9.3.12. Sweden
9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
9.3.12.2. Sweden Market Size and Forecast, By Treatment, 2017 - 2028 (US$ Million)
9.3.12.3. Sweden Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
9.3.13. Poland
9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
9.3.13.2. Poland Market Size and Forecast, By Treatment, 2017 - 2028 (US$ Million)
9.3.13.3. Poland Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
9.3.14. Rest of Europe
9.3.14.1. Overview
9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
9.3.14.3. Rest of the Europe Market Size and Forecast, By Treatment, 2017 - 2028 (US$ Million)
9.3.14.4. Rest of the Europe Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
9.4. Asia Pacific (APAC)
9.4.1. Overview
9.4.2. Key Manufacturers in Asia Pacific
9.4.3. Asia Pacific Market Size and Forecast, By Country, 2017 - 2028 (US$ Million)
9.4.4. Asia Pacific Market Size and Forecast, By Treatment, 2017 - 2028 (US$ Million)
9.4.5. Asia Pacific Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
9.4.6. India
9.4.6.1. Overview
9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
9.4.6.3. India Market Size and Forecast, By Treatment, 2017 - 2028 (US$ Million)
9.4.6.4. India Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
9.4.7. China
9.4.7.1. Overview
9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
9.4.7.3. China Market Size and Forecast, By Treatment, 2017 - 2028 (US$ Million)
9.4.7.4. China Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
9.4.8. Japan
9.4.8.1. Overview
9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
9.4.8.3. Japan Market Size and Forecast, By Treatment, 2017 - 2028 (US$ Million)
9.4.8.4. Japan Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
9.4.9. South Korea
9.4.9.1. Overview
9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
9.4.9.3. South Korea Market Size and Forecast, By Treatment, 2017 - 2028 (US$ Million)
9.4.9.4. South Korea Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
9.4.10. Australia
9.4.10.1. Overview
9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
9.4.10.3. Australia Market Size and Forecast, By Treatment, 2017 - 2028 (US$ Million)
9.4.10.4. Australia Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
9.4.11. Thailand
9.4.11.1. Overview
9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
9.4.11.3. Thailand Market Size and Forecast, By Treatment, 2017 - 2028 (US$ Million)
9.4.11.4. Thailand Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
9.4.12. Indonesia
9.4.12.1. Overview
9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
9.4.12.3. Indonesia Market Size and Forecast, By Treatment, 2017 - 2028 (US$ Million)
9.4.12.4. Indonesia Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
9.4.13. Philippines
9.4.13.1. Overview
9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
9.4.13.3. Philippines Market Size and Forecast, By Treatment, 2017 - 2028 (US$ Million)
9.4.13.4. Philippines Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
9.4.14. Rest of APAC
9.4.14.1. Overview
9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
9.4.14.3. Rest of APAC Market Size and Forecast, By Treatment, 2017 - 2028 (US$ Million)
9.4.14.4. Rest of APAC Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
9.5. Latin America
9.5.1. Overview
9.5.2. Key Manufacturers in Latin America
9.5.3. Latin America Market Size and Forecast, By Country, 2017 - 2028 (US$ Million)
9.5.4. Latin America Market Size and Forecast, By Treatment, 2017 - 2028 (US$ Million)
9.5.5. Latin America Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
9.5.6. Brazil
9.5.6.1. Overview
9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
9.5.6.3. Brazil Market Size and Forecast, By Treatment, 2017 - 2028 (US$ Million)
9.5.6.4. Brazil Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
9.5.7. Mexico
9.5.7.1. Overview
9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
9.5.7.3. Mexico Market Size and Forecast, By Treatment, 2017 - 2028 (US$ Million)
9.5.7.4. Mexico Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
9.5.8. Argentina
9.5.8.1. Overview
9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
9.5.8.3. Argentina Market Size and Forecast, By Treatment, 2017 - 2028 (US$ Million)
9.5.8.4. Argentina Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
9.5.9. Colombia
9.5.9.1. Overview
9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
9.5.9.3. Colombia Market Size and Forecast, By Treatment, 2017 - 2028 (US$ Million)
9.5.9.4. Colombia Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
9.5.10. Rest of LATAM
9.5.10.1. Overview
9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
9.5.10.3. Rest of LATAM Market Size and Forecast, By Treatment, 2017 - 2028 (US$ Million)
9.5.10.4. Rest of LATAM Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
9.6. Middle East and Africa
9.6.1. Overview
9.6.2. Key Manufacturers in Middle East and Africa
9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2017 - 2028 (US$ Million)
9.6.4. Middle East and Africa Market Size and Forecast, By Treatment, 2017 - 2028 (US$ Million)
9.6.5. Middle East and Africa Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
9.6.6. Saudi Arabia
9.6.6.1. Overview
9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
9.6.6.3. Saudi Arabia Market Size and Forecast, By Treatment, 2017 - 2028 (US$ Million)
9.6.6.4. Saudi Arabia Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
9.6.7. United Arab Emirates
9.6.7.1. Overview
9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
9.6.7.3. United Arab Emirates Market Size and Forecast, By Treatment, 2017 - 2028 (US$ Million)
9.6.7.4. United Arab Emirates Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
9.6.8. Israel
9.6.8.1. Overview
9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
9.6.8.3. Israel Market Size and Forecast, By Treatment, 2017 - 2028 (US$ Million)
9.6.8.4. Israel Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
9.6.9. Turkey
9.6.9.1. Overview
9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
9.6.9.3. Turkey Market Size and Forecast, By Treatment, 2017 - 2028 (US$ Million)
9.6.9.4. Turkey Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
9.6.10. Algeria
9.6.10.1. Overview
9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
9.6.10.3. Algeria Market Size and Forecast, By Treatment, 2017 - 2028 (US$ Million)
9.6.10.4. Algeria Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
9.6.11. Egypt
9.6.11.1. Overview
9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
9.6.11.3. Egypt Market Size and Forecast, By Treatment, 2017 - 2028 (US$ Million)
9.6.11.4. Egypt Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
9.6.12. Rest of MEA
9.6.12.1. Overview
9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
9.6.12.3. Rest of MEA Market Size and Forecast, By Treatment, 2017 - 2028 (US$ Million)
9.6.12.4. Rest of MEA Market Size and Forecast, By End User, 2017 - 2028 (US$ Million)
10. Key Vendor Analysis
10.1. Competitive Dashboard
10.2. Company Profiles
10.2.1. Abbott
10.2.2. Boehringer Ingelheim GmbH
10.2.3. GlaxoSmithKline plc
10.2.4. Pfizer, Inc.
10.2.5. Sanofi
10.2.6. Merck & Co., Inc.
10.2.7. Teva Pharmaceutical Industries Ltd.
10.2.8. Boston Scientific Corporation
10.2.9. Teleflex Incorporated
10.2.10. Endo International plc
10.2.11. Urologix, LLC
10.2.12. LISA Laser Surgeries
10.2.13. Olympus Corporation
11. 360 Degree Analyst View
12. Appendix
12.1. Research Methodology
12.2. References
12.3. Abbreviations
12.4. Disclaimer
12.5. Contact Us
